Characteristics | Patients No. = 49 (%) | Evaluable patients N = 40 (%) |
Median age “range, years” | 60 “43 - 70” | 58 “43 - 70” |
Sex: |
|
|
Male | 38 (77.55) | 30 (75) |
Female | 11 (22.45) | 10 (25) |
Performance status “ECOG”: |
|
|
0 | 15 (30.61) | 14 (35) |
1 | 19 (38.78) | 18 (45) |
2 | 15 (30.61) | 8 (20) |
Cirrhosis: |
|
|
Yes | 42 (85.71) | 33 (82.5) |
No | 7 (14.29) | 7 (17.5) |
Etiology: |
|
|
Hepatitis B virus | 7 (14.29) | 5 (12.5) |
Hepatitis C virus | 36 (73.47 | 30 (75) |
Hepatitis B & C virus | 3 (6.12) | 2 (5) |
Unknown | 3 (6.12) | 3 (7.5) |
Portal vein thromboses: |
|
|
Yes | 29 (59.18) | 20 (50) |
No | 20 (40.82) | 20 (50) |
Αlpha-Fetoprotein: |
|
|
Elevated | 43(87.8%) | 34 (85) |
Normal | 6 (12.2%) | 6 (15) |
Liver function by Child-Pugh stage: |
|
|
A | 11 (22.45) | 9 (22.5) |
B | 29 (59.18) | 26 (65) |
C | 9 (18.37) | 5 (12.5) |
BCLC stage*: |
|
|
B | 17 (34.69) | 16 (40) |
C | 32 (65.31) | 24 (60) |
Pain (painful hepatomegaly): |
|
|
Yes | 30 (61.22)) | 30 (75)) |
No | 19 (38.78) | 10 (25) |